Tectonic Therapeutic, Inc. Common Stock (TECX) is a publicly traded Healthcare sector company. As of May 21, 2026, TECX trades at $28.84 with a market cap of $522.68M and a P/E ratio of -6.89. TECX moved +5.61% today. Year to date, TECX is +46.32%; over the trailing twelve months it is +17.43%. Its 52-week range spans $13.70 to $61.07. Analyst consensus is strong buy with an average price target of $80.71. Rallies surfaces TECX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TECX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $28.84 |
| Market Cap | $522.68M |
| P/E Ratio | -6.89 |
| EPS | $-4.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $61.07 |
| 52-Week Low | $13.70 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $-80.32M |
| Net Income | $-74.15M |
| Gross Margin | 0.00% |
8 analysts cover TECX: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $80.71.